Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis

• Mitsuru Ishii,
• Masaharu Akao,
• Satoshi Yasuda,
• Koichi Kaikita,
• Junya Ako,
• Tetsuya Matoba,
• Masato Nakamura,
• Katsumi Miyauchi,
• Nobuhisa Hagiwara,
• Kazuo Kimura,
• Atsushi Hirayama,
• Kunihiko Matsui,
• Hisao Ogawa

Affiliations

Mitsuru Ishii

Department of Cardiology National Hospital Organization Kyoto Medical Center Kyoto Japan

Masaharu Akao

Department of Cardiology National Hospital Organization Kyoto Medical Center Kyoto Japan

Satoshi Yasuda

Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan

Koichi Kaikita

Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine University of Miyazaki Miyazaki Japan

Junya Ako

Department of Cardiovascular Medicine Kitasato University School of Medicine Sagamihara Japan

Tetsuya Matoba

Department of Cardiovascular Medicine, Faculty of Medical Sciences Kyushu University Fukuoka Japan

Masato Nakamura

Division of Cardiovascular Medicine Toho University Ohashi Medical Center Tokyo Japan

Katsumi Miyauchi

Department of Cardiovascular Medicine Juntendo Tokyo Koto Geriatric Medical Center Tokyo Japan

Nobuhisa Hagiwara

Department of Cardiology Tokyo Women’s Medical University Tokyo Japan

Kazuo Kimura

Cardiovascular Center Yokohama City University Medical Center Yokohama Japan

Atsushi Hirayama

Department of Cardiology Osaka Police Hospital Osaka Japan

Kunihiko Matsui

Department of General Medicine and Primary Care Kumamoto University Hospital Kumamoto Japan

Hisao Ogawa

Kumamoto University Kumamoto Japan